LIMES SCHLOSSKLINIKEN AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 346 EUR | -1.14% |
|
-2.26% | +21.83% |
| Feb. 06 | LIMES Schlosskliniken AG Provides Earnings Guidance for the First Half and Year 2024 | CI |
| 2023 | LIMES Schlosskliniken AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2024 | 2025 |
|---|---|---|---|---|
| Capitalization 1 | 29.91 | 60.4 | 101.4 | - |
| Enterprise Value (EV) 1 | 29.91 | 60.4 | 101.4 | 101.4 |
| P/E ratio | -43 x | 15.3 x | - | - |
| Yield | - | - | - | - |
| Capitalization / Revenue | - | - | 2.34 x | 1.81 x |
| EV / Revenue | - | - | 2.34 x | 1.81 x |
| EV / EBITDA | - | - | 9.43 x | 7.29 x |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Price to Book | - | - | - | - |
| Nbr of stocks (in thousands) | 293 | 293 | 293.2 | - |
| Reference price 2 | 102.0 | 206.0 | 346.0 | 346.0 |
| Announcement Date | 5/14/21 | 4/29/22 | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2024 | 2025 |
|---|---|---|---|---|
| Net sales 1 | - | - | 43.29 | 55.98 |
| EBITDA 1 | - | - | 10.75 | 13.91 |
| EBIT 1 | - | - | 6.963 | 10.81 |
| Operating Margin | - | - | 16.09% | 19.3% |
| Earnings before Tax (EBT) | - | - | - | - |
| Net income | -0.6944 | 3.944 | - | - |
| Net margin | - | - | - | - |
| EPS | -2.370 | 13.45 | - | - |
| Free Cash Flow | - | - | - | - |
| FCF margin | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 5/14/21 | 4/29/22 | - | - |
1EUR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2024 | 2025 |
|---|---|---|---|---|
| Net Debt | - | - | - | - |
| Net Cash position | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - |
| Free Cash Flow | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - |
| Assets | - | - | - | - |
| Book Value Per Share | - | - | - | - |
| Cash Flow per Share | - | - | - | - |
| Capex | - | - | - | - |
| Capex / Sales | - | - | - | - |
| Announcement Date | 5/14/21 | 4/29/22 | - | - |
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
346
EUR
Average target price
632
EUR
Spread / Average Target
+82.66%
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +21.83% | 108M | |
| -20.16% | 16.21B | |
| +4.50% | 12.44B | |
| +3.98% | 11.58B | |
| +9.72% | 10.79B | |
| +23.61% | 8.26B | |
| -2.19% | 7.68B | |
| +20.75% | 7.2B | |
| +4.49% | 6.67B | |
| +50.89% | 4.66B |
- Stock Market
- Equities
- LIK Stock
- Financials LIMES Schlosskliniken AG
